Karrm Health Management & Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2021
- Revenue %
(FY 2020)
- Profit 32.26%
(FY 2020)
- Ebitda 48.39%
(FY 2020)
- Net Worth -28.53%
(FY 2020)
- Total Assets %
(FY 2020)
About Karrm Health Management & Chemicals
The Corporate was formerly known as Ekkta Health Management & Chemicals Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ramakanth Jadhav and Ketan Patel serve as directors at the Company.
- CIN/LLPIN
U24100MH2011PTC217700
- Company No.
217700
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 May 2011
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Karrm Health Management & Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramakanth Jadhav  | Director | 20-May-2011 | Current |
| Ketan Patel | Director | 20-May-2011 | Current |
Financial Performance and Corporate Structure Insights of Karrm Health Management & Chemicals.
Karrm Health Management & Chemicals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 32.26% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Karrm Health Management & Chemicals?
In 2019, Karrm Health Management & Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Karrm Brahmaand Affordable Homes Private LimitedActive 11 years 5 months
Ramakanth Jadhav is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Karrm Health Management & Chemicals?
Unlock and access historical data on people associated with Karrm Health Management & Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Karrm Health Management & Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Karrm Health Management & Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
